TREM1 and pancreatic adenocarcinoma: The OS results indicated that TREM1 is a risk factor for patients with glioblastoma multiforme (GBM), kidney renal clear cell carcinoma (KIRC), lower grade glioma (LGG), liver hepatocellular carcinoma (LICH), mesothelioma (MESO), pancreatic adenocarcinoma (PAAD) and stomach adenocarcinoma (STAD).